http://www.ncbi.nlm.nih.gov/pubmed/18794105
Tamoxifen, aromatase inhibitors, and CYP2D6 testing
Submitted by Anonymous on Fri, 2010-01-22 21:13- Aromatase
- Aromatase inhibitor
- AstraZeneca
- Breast cancer
- breast cancer care
- Business
- Business
- Cancer
- cancer care
- chemical
- CYP2D6
- Cytochrome P450
- http://www.ncbi.nlm.nih.gov/pubmed/18445827
- http://www.ncbi.nlm.nih.gov/pubmed/18794105
- human genome
- Medicine
- Medicine
- Ned Waller
- Pharmaceutical drug
- pharmacogenomic
- Quotation
- Selective estrogen receptor modulators
- Social Issues
- Social Issues
- Tamoxifen
- Technology
- Technology
- Treatment of bipolar disorder
The 1960s brought flower power and also the invention of Tamoxifen. Tamoxifen reduced breast cancer recurrence by 50%, and women everywhere rejoiced.
»
- Read more
- 3323 reads
